Efficacy - Confidence in IOP Control
Long-term results from National University Hospital (NUHS), Singapore prospective clinical study1 showed:
- 33% IOP reduction at 18 months, N = 38 patients
- 61% med reduction (2.1 to 1.3)
- 73% success rate with 1.3 sessions
|
NUHS Clinical Study2
Multi-Center Respective Data1,3
 |
1. Radcliffe N, Vold S, Kammer J, Ahmed I, Parekh P, Noecker R, Khatana A. MicroPulse Trans-scleral Cyclophotocoagulation (mTSCPC) for the Treatment of Glaucoma Using the MicroPulse P3 Device. AGS, San Diego February 26 - March 1, 2015.
2. Tan A, Chockalingam M, Aquino M, Lim Z, See J, Chew P. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Experiment Ophthalmol. 2010;38(3):266-72
3. Jeffrey Kammer, MD, Vanderbilt Eye Institute, Nashville, TN | Anup Khatana, MD, Cincinnati Eye Institute, Cincinnati, OH | Robert Noecker, MD, MBA, Ophthalmic Consultants of Connecticut, Fairfield, CT | Parag Parekh, MD, MPA, Laurel Eye Clinic, Brookville, PA Nathan Radcliffe, ND, Weill Cornell Medical College, New York, NY | Steven Vold, MD, Vold Vision, LLC, Fayetteville, AR
Excellent Safety Profile The MicroPulse® P3 Glaucoma Device powered by the CYCLO G6™ Glaucoma Laser System enables a versatile procedure with multiple safety benefits: - Non-Incisional
- Minimal to no inflammation post-op
- Patient downtime is significantly low
- Repeatable
- Predictable
|  Pre treatment  Post Treatment with MP3. No detectable evidence of tissue damage. Images courtesy of A/Professor Paul Chew, NUHS | 2014 Randomized study shows MicroPulse P3 has similar IOP reduction as G-Probe with higher success rate and no hypotony1 | | MicroPulse TSCPC | TSCPC | | Pre-op IOP | 36.5 mmHg | 35.0 mmHg | | N Total of 48 | 24 pts | 24 pts | | Average Follow-up | 17.5 months | 17.5 months | | IOP Reduction | 45% | 45% | | Success Rate (<21 mmHg at 18 months) | 75% | 29% | | Prologed Hypotony | 0 | 5 | | Mean # of Treatments | 1.6 | 1.3 | 1. Aquino M, Barton K, Tan A, Sng C, Loon SC, Chew P. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Experiment Ophthalmol. 2015 Jan;43(1):40-6. doi 10.111/ceo. 12360 Epub 2014 Jun 21
Glaucoma Therapy Device Options The patented MicroPulse® P3 and G-Probe™ devices are used to deliver laser energy for the treatment of glaucoma.  What is the treatment technique for the MicroPulse P3 (MP3) Probe?  For additional detailed instructions please refer to the IRIDEX MicroPulse P3 Device Instrumentation Instructions for Use. What is the treatment technique for the G-Probe?  For additional detailed instructions please refer to the IRIDEX G-Probe Instrumentation Instructions for Use. 1. Aquino M, Barton K, Tan A, Sng C, Loon SC, Chew P. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Experiment Ophthalmol. 2015 Jan;43(1):40-6. doi 10.111/ceo. 12360 Epub 2014 Jun 21.
2. Radcliffe N, Vold S, Kammer J, Ahmed I, Parekh P, Noecker R, Khatana A. MicroPulse Trans-scleral Cyclophotocoagulation (mTSCPC) for the Treatment of Glaucoma Using the MicroPulse P3 Device. AGS, San Diego February 26 - March 1, 2015.
 | “The MicroPulse P3 device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye. ” Robert Noecker, MD, MBA |  | “The MicroPulse P3 device has given me over 30% IOP lowering. With patients that are non-compliant with their medication, or we are really trying to keep off their medication, the MicroPulse P3 device allows me to treat patients more aggressively.” Steven Vold, MD |
| |
|
Glaucoma Treatments for Today... & Tomorrow
Robert Noecker, MD, MBA
|
| |
|
MP3 Treatment Technique
Robert Noecker, MD, MBA
|
| |
|
Early Work on New TSCPC Laser Therapy
Maria Cecilia D. Aquino, MD, MMED, Ophthalmology
|
1. What is MicroPulse® Technology?
MicroPulse technology is a tissue-sparing solution where a continuous-wave laser beam is chopped into a train of tiny, repetitive, low energy pulses separated by a brief rest period which allows tissue to cool between laser pulses.
2. What is the treatment technique for the MicroPulse P3 (MP3) Probe?
For additional detailed instructions please refer to the IRIDEX MicroPulse P3 Device Instrumentation Instructions for Use.
3. What is the treatment technique for the G-Probe?
For additional detailed instructions please refer to the IRIDEX G-Probe Instrumentation Instructions for Use.
4. What is the shelf life of the MicroPulse P3 probe and the G-Probe?
3 years
5. Are the MicroPulse P3 probe and the G-Probe single-use devices?
Yes, the MicroPulse P3 probe and G-Probe are validated for single-use only.
6. What is the CPT code?
66710
7. What does 66710 pay?
| |
Physician Office Setting |
ASC |
Hospital Outpatient Dept. |
| Probe |
Physician Payment |
Physician Payment |
Facility Payment |
Physician Payment |
Facility Payment |
| MicroPulse P3 |
$445 |
$398 |
$842 |
$398 |
$1,535 |
| G-Probe |
$445 |
$398 |
$842 |
$398 |
$1,535 |
*
8. What are the part numbers?
| Product |
Product Number |
Units per Box |
| MicroPulse P3 Probe |
15522 |
6 |
| G-Probe |
15980 |
6 |
| CYCLO G6 Laser Console |
CYCLO-G6-SYSTEM |
- |
9. What is the patent number for the MicroPulse P3 device?
PATENT NO. 8,945,103
10. What is the FDA 510(k) number?
K143154
*Reimbursement figures are based on US national averages. Please consult your local Medicare and non-Medicare carriers for coverage and payment policies.
*Currently available in US only.
|
|
|